There is evidence to suggest that epigenetic changes and preferential methylation of sites within the BRCA1 promoter region can lead to this down-regulation of expression; however, collectively, these mechanisms are implicated in only a small percentage of sporadic tumours [6]. This evidence concerns the gene BRCA1 and neoplasm.